A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion
JCI Insight · 2025
DOI: 10.1172/jci.insight.199200 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Carolina M Larrain und 18 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Oncology Program. Hauptthemen laut MEDLINE: Proteasome Inhibitors, Oligopeptides, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), the S. Ritterbush Fund, and the MIT Center for Preci….
Abstract (Originalsprache)
Targeting tumors with proteosome inhibitors has demonstrated antitumor activity and has been successfully translated to the clinic for patients with multiple myeloma. However, in patients with solid tumors, treatment with proteosome inhibitors as single agents has consistently failed to yield meaningful responses. In our study, we investigate the potential of hepatic artery infusion pump delivery of carfilzomib, to continuously direct a large dose to the tumor with least hepatic toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Surgical Oncology Program.
- Genitourinary Malignancies Branch, and.
- Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Förderung
- This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), the S. Ritterbush Fund, and the MIT Center for Preci…
Zitieren
APA
Larrain, C. M., Victory, J. H., Desai, P. P., Friedman, L. R., Stepp, H., Ashe, R., Remmert, K., Sinha, S., Smith, E. C., Russell, N., Pu, T., Eade, A. V., Burke, J. F., Ho, J., Yaffe, M. B., Kleiner, D. E., Schmidt, K., Figg, W. D., & Hernandez, J. M. (2025). A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion. JCI Insight. https://doi.org/10.1172/jci.insight.199200
Vancouver
Larrain CM, Victory JH, Desai PP, Friedman LR, Stepp H, Ashe R, et al. A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion. JCI Insight. 2025. doi:10.1172/jci.insight.199200
BibTeX
@article{Larrain2025,
author = {Larrain, Carolina M and Victory, Jack H and Desai, Priyanka P and Friedman, Lindsay R and Stepp, Hannah and Ashe, Rachel and Remmert, Kirsten and Sinha, Surajit and Smith, Emily C and Russell, Nicole and Pu, Tracey and Eade, Alyssa V and Burke, Justine F and Ho, Jason and Yaffe, Michael B and Kleiner, David E and Schmidt, Keith and Figg, William D and Hernandez, Jonathan M},
title = {A rebrand for proteasome inhibition in solid tumors via continuous hepatic artery infusion},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.199200}
}
EUVIMED